Activation of Xenopus Chk1 by mutagenesis of threonine-377  by Wang, Sophie X & Dunphy, William G
Activation of Xenopus Chk1 by mutagenesis of threonine-377
Sophie X. Wang, William G. Dunphy*
Division of Biology 216-76, Howard Hughes Medical Institute, California Institute of Technology, 1200 East California Blvd., Pasadena,
CA 91125, USA
Received 24 November 2000; revised 29 November 2000; accepted 1 December 2000
First published online 12 December 2000
Edited by Giulio Superti-Furga
Abstract Xenopus Chk1 (Xchk1) is required for the check-
point-associated delay of the cell cycle in frog egg extracts
containing unreplicated or UV-damaged DNA. Phosphorylation
of Xchk1 at multiple sites in the SQ/TQ domain (residues 314^
366) in response to unreplicated or UV-damaged DNA results in
elevation of its kinase activity. We have found that mutagenesis
of Thr-377 in the conserved Thr^Arg^Phe (TRF) motif of Xchk1
also leads to a substantial increase in kinase activity. Thr-377
does not appear to be a site of phosphorylation in Xchk1. These
findings suggest that Thr-377 may play a role in suppressing the
activity of Xchk1. ß 2000 Federation of European Biochemi-
cal Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
In eukaryotic cells, the entry into mitosis is controlled by
maturation or M-phase promoting factor (MPF). In verte-
brates, MPF consists of the protein kinase Cdc2, a B-type
cyclin, and the Suc1/Cks protein [1,2]. During interphase,
the activity of MPF is normally suppressed by inhibitory
phosphorylations on the Thr-14 and Tyr-15 residues of
Cdc2. These inhibitory phosphorylations are carried out by
the kinases Myt1 and Wee1. When the conditions are appro-
priate for mitosis, the dual-speci¢city phosphatase Cdc25 de-
phosphorylates these key sites and thereby generates the active
form of MPF.
Consistent with its crucial role in cell division, the activity
of MPF is subject to stringent regulation during the cell cycle
[2]. For example, MPF cannot become active, and thus cell
division cannot occur, if the genomic DNA has not been
replicated properly or has su¡ered damage. These regulatory
processes have been designated the DNA replication and
DNA damage checkpoints, respectively [3^5]. Largely from
genetic studies in budding and ¢ssion yeast, it is understood
that these checkpoint pathways consist of sensor proteins that
detect unreplicated/damaged DNA and e¡ector proteins that
regulate downstream targets such as cell cycle control factors.
In the case of ¢ssion yeast, for example, the kinases Chk1 and
Cds1 are important mediators in these regulatory circuits
[4,5]. Both Chk1 and Cds1 possess close structural homologs
in budding yeast, humans, Xenopus, and other species [6^12].
A variety of studies have indicated that Chk1 and Cds1 neg-
atively regulate Cdc25 by phosphorylating it on one or more
14-3-3 binding sites, depending on the organism [6,8,13^16].
We have been studying the functional properties of Xenopus
Chk1 (Xchk1) by using extracts from Xenopus eggs. Previ-
ously, our laboratory demonstrated that Xchk1 is essential
for an appropriate cell cycle delay in response to unreplicated
or UV-damaged DNA [8]. Xchk1 becomes highly phosphor-
ylated in the presence of unreplicated or UV-damaged DNA.
This process involves both phosphorylation in the conserved
SQ/TQ domain of Xchk1 and autophosphorylation [8,17,18].
The checkpoint-triggered phosphorylation of Xchk1 brings
about an increase in its kinase activity [17]. Furthermore,
this phosphorylation is required for a normal checkpoint re-
sponse [18]. In this study, we have found that various mutants
in a conserved region of Xchk1 containing Thr-377 display
highly increased kinase activity. The potential implications of
these ¢ndings for the structure and regulation of Xchk1 are
discussed.
2. Materials and methods
2.1. Production of recombinant Xchk1 proteins
Wild-type and mutant His6-Xchk1 proteins were puri¢ed from ba-
culovirus-infected Sf9 cells as described [8]. Plasmids encoding His6-
Xchk1 proteins were constructed in pFastBacHTa vectors (Gibco
BRL). 35S-labeled Xchk1 proteins were synthesized using the ap-
propriate pBS-Xchk1 plasmids as templates in the TNT in vitro
transcription/translation system (Promega Corp.) in the presence of
[35S]Translabel (ICN Biomedicals) as described [8].
Mutations in Xchk1 were created with the QuikChange1 site-di-
rected mutagenesis kit (Stratagene) using the following oligonucleo-
tides: T377A (BssHII): 5P-CGTTTGGTCAAAAGGATGGCGCG-
CTTCTTTACAAAAGTGAATGCC-3P and 5P-GGCATTCACTTT-
TGTAAAGAAGCGCGCCATCCTTTTGACCAAACG- 3P ; T377E
(SpeI): 5P-GTTTGGCAGCGACTAGTCAAAAGGATGGAGAGG-
TTCTTTAC-3P and 5P-GTAAAGAACCTCTCCATCCTTTTGACT-
AGTCGCTGCCAAAC-3P ; and vKRMTRFF (BssSI): 5P-GTTTGG-
CAGCGTCTCGTGACAAAAGTGAATGCC-3P and 5P-GGCATT-
CACTTTTGTCACGAGAGGCTGCCAAAC-3P. Shown in the pa-
rentheses are the restriction sites generated by silent mutations in
the coding region of the primers that allow for the identi¢cation of
the mutant clone. All mutations have been con¢rmed by DNA se-
quencing analysis.
2.2. Egg extracts and isolation of nuclear fractions
Xenopus egg extracts were prepared as described [19]. Reticulocyte
lysates containing 35S-labeled Xchk1 proteins were added to inter-
phase egg extracts supplemented with 100 Wg/ml cycloheximide. De-
membranated Xenopus sperm (3000 nuclei/Wl of extract) were added to
the extracts in the absence or presence of 50 Wg/ml aphidicolin. To
isolate the nuclear fraction, 50 Wl of egg extract was loaded (after
incubation at 23‡C for 100 min) onto 0.5 ml of a pre-chilled sucrose
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solution (1 M sucrose in 80 mM KCl, 25 mM K-gluconate, 10 mM
Mg-gluconate, 20 mM HEPES^KOH, pH 7.5) and then centrifuged at
6600Ug for 5 min in a swinging bucket rotor in an Eppendorf cen-
trifuge (model 5417C, Eppendorf Scienti¢c, Inc.). The pellets were
resuspended gently in the same bu¡er and recentrifuged at 6600Ug
for 5 min. The supernatants were discarded and the ¢nal pellets were
boiled in SDS gel loading bu¡er and analyzed by SDS^PAGE.
2.3. Kinase assays
His6-Xchk1 proteins were incubated with GST-Cdc25(254^316)-
WT [8] in 20 Wl of kinase bu¡er (5 mM Tris^HCl, pH 8.0, 10 mM
MgCl2, 1 mM DTT, 0.1 mg/ml ovalbumin, 5 WCi [Q-32P]ATP, and 50
WM ATP). The kinase mixtures were incubated at 23‡C for 15 min
before SDS gel loading bu¡er was added.
2.4. In vivo 32P-labeling and isolation of His6-Xchk1 proteins
Baculovirus-infected Sf9 cells were incubated in normal growth me-
dium for 40^45 h before harvesting. The harvested cells were washed
three times in phosphate-free minimal essential medium (MEM) (Gib-
co BRL). The washed cell pellet was then resuspended in the same
medium containing 32P-labeled orthophosphate (0.5 mCi/ml) and
1.5% dialyzed fetal bovine serum (Gibco BRL). After incubation at
23‡C for 4.5 h, the cells were collected and washed twice in HEPES-
bu¡ered saline (HBS) as described [8]. The labeled recombinant
Xchk1 proteins were isolated using nickel agarose beads as described
[8]. Phosphoamino acid analysis and phosphopeptide mapping were
performed as described [20].
3. Results
3.1. Mutagenesis of Thr-377 stimulates hyperphosphorylation
of Xchk1
As described previously, Xchk1 in Xenopus egg extracts
undergoes hyperphosphorylation during a checkpoint re-
sponse to unreplicated DNA (induced by treatment with the
DNA polymerase inhibitor aphidicolin) or UV-damaged
DNA [8]. This phosphorylation occurs in the conserved SQ/
TQ domain of Xchk1 (see Fig. 1A). An example of the phos-
phorylation of 35S-labeled Xchk1 that is triggered by aphidi-
colin is depicted in Fig. 1B (compare lanes 1 and 2). This
checkpoint-associated phosphorylation is abolished in the
Xchk1-4AQ mutant in which the four Ser/Thr residues (e.g.
Thr-314, Ser-344, Ser-356, and Ser-365) in the SQ/TQ motifs
of Xchk1 have all been mutated to alanine [17,18] (see also
Fig. 1B, lanes 1^4). In parallel with these studies, we prepared
a mutant of Xchk1 containing alanine instead of threonine at
position 377 (Fig. 1A). Thr-377 lies in a region of Xchk1 that
is highly conserved in the Chk1 family of proteins [8], which
we will refer to as the TRF (Thr^Arg^Phe) motif. We ob-
served that the 35S-labeled Xchk1-T377A protein underwent
an upshift of electrophoretic mobility in both the absence and
presence of aphidicolin, though the phosphorylation was
greater in the presence of aphidicolin (Fig. 1B, lanes 7 and
8). Similar results were obtained with a related mutant
Fig. 1. Mutagenesis of threonine-377 in the conserved TRF motif of Xchk1. A: Sequence alignment of the Chk1 proteins from Xenopus, hu-
mans, Drosophila (grapes), and Schizosaccharomyces pombe in the SQ/TQ and TRF regions (top). Schematic representation of the locations of
the kinase domain, SQ/TQ domain, and TRF motif in Xchk1 (bottom). The Thr-314, Ser-344, Ser-356, Ser-365, and Thr-377 residues in Xchk1
are denoted with arrows. B: Modi¢cation of various 35S-labeled Xchk1 proteins in Xenopus egg extracts. 35S-labeled Xchk1 proteins (WT,
4AQ, 4AQ/T377A, T377A, and vKRMTRFF) were incubated in interphase egg extracts containing 3000 sperm nuclei/Wl in the presence (+) or
absence (3) of 50 Wg/ml aphidicolin. An aliquot (50 Wl) of each extract was centrifuged through a sucrose cushion to isolate the nuclear frac-
tions (see Section 2), which were then subjected to SDS^PAGE and autoradiography.
FEBS 24461 27-12-00
S.X. Wang, W.G. Dunphy/FEBS Letters 487 (2000) 277^281278
(Xchk1-vKRMTRFF) in which residues 374^380 were deleted
(Fig. 1B, lanes 9 and 10). Finally, phosphorylation due to
disruption of Thr-377 was strongly reduced but not com-
pletely abolished in a combination mutant (Xchk1-4AQ/
T377A) in which Thr-377 as well as Thr-314, Ser-344, Ser-
356, and Ser-365 were all changed to alanine (Fig. 1B, lanes
5 and 6).
3.2. Mutagenesis of Thr-377 leads to a strong stimulation of
Xchk1 activity
In order to assess whether Thr-377 plays a role in kinase
activity, we prepared His6-Xchk1-T377A in baculovirus-in-
fected Sf9 cells. Next, we compared the kinase activity of
His6-Xchk1-T377A and wild-type His6-Xchk1. As indicators
of kinase activity, we measured the ability of these proteins to
phosphorylate themselves (i.e. autophosphorylation) and the
exogenous substrate GST-Cdc25(254^316)-WT. As shown in
Fig. 2A, His6-Xchk1-T377A was considerably more active
(10^15-fold) than wild-type Xchk1. A form of Xchk1 contain-
ing both the mutations T377A and N135A (which eliminates
the catalytic function of Xchk1) [8], did not possess detectable
kinase activity (Fig. 2B). This observation implies that the
increased activity of His6-Xchk1-T377A is an intrinsic feature
of this mutant and not, for example, due to association with
another kinase activity. As shown in Fig. 3, the kinase activity
of Xchk1 was also highly elevated in a mutant in which seven
residues containing Thr-377 were deleted (vKRMTRFF). Fi-
nally, alteration of Thr-377 to a negatively charged amino
acid (e.g. glutamic acid) to yield the Xchk1-T377E mutant
likewise resulted in increased activity (Fig. 3).
As described previously, residues in the SQ/TQ domain (e.g.
Thr-314, Ser-344, Ser-356, and Ser-365) are required for the
checkpoint-associated phosphorylation and activation of
Xchk1 [17,18]. To ask whether these residues play a role in
the elevated kinase activity of the T377A mutant, we prepared
a combination mutant (4AQ/T377A) in which Thr-314, Ser-
344, Ser-356, Ser-365, and Thr-377 were all mutated to ala-
nine. As shown in Fig. 3, the His6-Xchk1-4AQ/T377A protein
is also approximately 15-fold more active than wild-type His6-
Xchk1. This ¢nding indicates that the stimulation of kinase
activity that occurs upon mutagenesis of Thr-377 occurs in-
dependently of phosphorylation on Thr-314, Ser-344, Ser-356,
or Ser-365.
3.3. Thr-377 does not appear to be a site of phosphorylation on
Xchk1
One explanation for the increased kinase activity of His6-
Xchk1-T377A would be that Thr-377 is required for a puta-
tive inhibitory phosphorylation of Xchk1. Since recombinant
His6-Xchk1-T377A that has been directly puri¢ed from bacu-
lovirus-infected Sf9 cells is already more active than His6-
Xchk1-WT, such an inhibitory phosphorylation would need
to have occurred in the Sf9 cells. To address this possibility,
we performed the following in vivo labeling experiment. Sf9
cells were infected with baculoviruses encoding His6-Xchk1-
WT or His6-Xchk1-T377A. Subsequently, the infected cells
were incubated in medium containing 32P-orthophosphate
for 4 h prior to puri¢cation of the recombinant Xchk1 pro-
teins. Finally, the 32P-labeled His6-Xchk1-WT and His6-
Xchk1-T377A proteins were subjected to phosphoamino
acid analysis and tryptic phosphopeptide mapping. As shown
in Fig. 4A, both His6-Xchk1-WT and His6-Xchk1-T377A
Fig. 2. The T377A mutant of Xchk1 displays increased in vitro ki-
nase activity. A: His6-Xchk1 recombinant proteins (WT, T377A,
and N135A) were assayed for Ser-287-speci¢c kinase activity using
GST-Cdc25(254^316)-WT as the substrate. The kinase reaction mix-
tures were then subjected to SDS^PAGE, Coomassie blue staining,
and autoradiography. Shown in the ¢gure are the autophosphoryla-
tion of the indicated His6-Xchk1 proteins (top), the phosphorylation
of GST-Cdc25(254^316)-WT (middle), and the Coomassie blue-
stained GST-Cdc25(254^316)-WT protein (bottom). The amounts of
the indicated Xchk1 protein used in lanes 1^13 were 25 ng, 50 ng,
100 ng, 200 ng, 200 ng, 500 ng, 1 Wg, 1 Wg, 50 ng, 100 ng, 200 ng,
400 ng, and 600 ng, respectively. Note that lanes 4 and 5 are dupli-
cates. B: The double mutant His6-Xchk1-N135A/T377A possesses
negligible kinase activity. His6-Xchk1 proteins (WT and N135A/
T377A) were assayed for autophosphorylation (top) and phosphory-
lation of GST-Xchk1(254^316)-WT (bottom) as described above in
(A). The amounts of the indicated Xchk1 protein used in lanes 1^6
were 62.5, 125, 250, 62.5, 125, and 250 ng, respectively.
Fig. 3. Further characterization of the role of Thr-377 in the kinase
activity of Xchk1. Various His6-Xchk1 proteins (WT, N135A/
T377A, T377A, T377E, vKRMTRFF, 4AQ, and 4AQ/T377A) were
assayed for kinase activity as described above. The histogram de-
picts phosphorylation of the substrate GST-Cdc25(254^316)-WT.
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contained exclusively phosphoserine with no detectable phos-
phothreonine or phosphotyrosine. In the tryptic phosphopep-
tide maps of each protein, we observed one major radiola-
beled spot (denoted with an arrow in Fig. 4B). In addition
to the major spot, the tryptic phosphopeptide map of His6-
Xchk1-T377A from 32P-labeled Sf9 cells contained a number
of less intensely radioactive spots. These tryptic phosphopep-
tides most probably contain additional sites of autophosphor-
ylation due to the increased ability of the T377A mutant to
phosphorylate itself. Taken together, these ¢ndings suggest
that Thr-377 is not a site of inhibitory phosphorylation.
This conclusion is based on the facts that His6-Xchk1-WT
contains no detectable phosphothreonine and does not yield
a tryptic phosphopeptide that is absent from the correspond-
ing map of the His6-Xchk1-T377A mutant. However, it is
possible that Thr-377 undergoes a modi¢cation that cannot
be detected by 32P-labeling.
3.4. Increased biological activity of His6-Xchk1-T377A in
Xenopus egg extracts
In order to characterize the T377A mutation further, we
assessed the biological activity of His6-Xchk1-T377A in Xeno-
pus egg extracts. As described previously, the addition of wild-
type His6-Xchk1 to Xenopus egg extracts results in a dose-
dependent delay of mitotic initiation [8]. The endogenous con-
centration of Xchk1 in egg extracts is approximately 2 ng/Wl.
As shown in Fig. 5A, the addition of 1.5 ng/Wl His6-Xchk1-
WT elicited a delay of 15^20 min, whereas a similar amount
of His6-Xchk1-T377A (1.8 ng/Wl) delayed mitotic initiation
by approximately 170 min. Similarly, there was a delay of
40 min in the presence of 3 ng/Wl His6-Xchk1-WT, while a
comparable concentration of His6-Xchk1-T377A (3.6 ng/Wl)
caused an essentially permanent arrest in interphase. By aver-
aging the cell cycle delay elicited at various kinase concentra-
tions, we determined that the T377A mutant is approximately
8-fold more active than wild-type Xchk1 in this assay (Fig.
5B). Thus, the increased kinase activity of the T377A mutant
is also re£ected in its increased potency in this biological as-
say.
4. Discussion
During a checkpoint response to unreplicated or UV-dam-
aged DNA, Xchk1 undergoes a marked hyperphosphoryla-
tion, which results in a substantial decrease in electrophoretic
mobility [8]. Mutagenesis of the serine and threonine residues
in the four conserved SQ/TQ motifs in Xchk1 abolishes this
checkpoint-dependent phosphorylation [17,18]. Signi¢cantly,
these SQ/TQ motifs comprise part of the consensus site for
phosphorylation by members of the DNA-dependent protein
kinase family (e.g. DNA-PK, ATM, and ATR) [21^24]. In
recent studies, we have shown that a Xenopus homolog of
ATR (Xatr) phosphorylates these sites [18]. Furthermore,
phosphorylation of the SQ/TQ domain is involved in the ac-
tivation of Xchk1 [17]. For this reason, the Xchk1-4AQ mu-
tant is unable to act as an e¡ector in the DNA replication
checkpoint [18].
The major ¢nding of this paper is that various mutants in
the TRF motif immediately adjacent to the SQ/TQ domain of
Xchk1 (e.g. T377A, T377E, and vKRMTRFF) exhibit a
strong increase in kinase activity. One explanation for this
¢nding would be that Thr-377 represents a site for inhibitory
phosphorylation. To address this possibility, we performed
phosphoamino acid analysis and tryptic phosphopeptide map-
Fig. 4. Phosphorylation of the His6-Xchk1-WT and His6-Xchk1-
T377A proteins in vivo in baculovirus-infected Sf9 cells. The indi-
cated His6-Xchk1 proteins were labeled in vivo with 32P, puri¢ed,
and characterized as described in Section 2. Shown in the ¢gure are
the phosphoamino acid analysis (A) and two-dimensional tryptic
phosphopeptide map (B) of each protein. S, phosphoserine; T,
phosphothreonine; Y, phosphotyrosine.
Fig. 5. The T377A mutant of Xchk1 displays increased potency in
delaying the cell cycle in Xenopus egg extracts. A: Puri¢ed His6-
Xchk1 recombinant proteins (WT, N135A, and T377A) were added
to the M-phase extracts (10% v/v) before activation of the extracts
with calcium. The ¢nal concentrations of the added proteins are in-
dicated in the ¢gure. The timing of NEB (nuclear envelope break-
down) was monitored by microscopy. B: Dose^response plot of the
data from (A).
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ping of the wild-type and T377A forms of His6-Xchk1 that
had been labeled in vivo with 32P in baculovirus-infected Sf9
cells. These studies indicated that wild-type and T377A His6-
Xchk1 contain phosphoserine but no detectable phospho-
threonine. Furthermore, the tryptic phosphopeptide map of
32P-labeled, wild-type His6-Xchk1 did not contain a radioac-
tive spot that was missing from the map of the T377A mutant.
Thus, it seems unlikely that the di¡erence in kinase activity
between wild-type and T377A His6-Xchk1 could be due to
phosphorylation on Thr-377.
Other possibilities are that the TRF motif in wild-type
Xchk1 is responsible for recruiting a negative regulator or
that mutants of Xchk1 with a defective TRF motif possess
a higher a⁄nity for a positive regulator, respectively. Such
regulators would necessarily be present in Sf9 insect cells,
because wild-type and T377A His6-Xchk1 (as well as the
T377E and vKRMTRFF mutants) assayed directly after pu-
ri¢cation from baculovirus-infected Sf9 cells show a large dif-
ference in kinase activity. However, we have not been able to
identify candidates for inhibitory or stimulatory factors in
preparations of recombinant Xchk1 from Sf9 cells.
Another type of explanation, which we presently favor,
would be that mutagenesis or deletion of Thr-377 leads to a
direct alteration (e.g. a structural change) that results in in-
creased kinase activity. For example, a number of kinases (e.g.
myosin light chain kinase and calmodulin-dependent protein
kinase I) are known to contain autoinhibitory regions that
suppress catalytic activity by various mechanisms [25]. Re-
cently, Chen et al. [26] reported the crystal structure of the
catalytic domain of human Chk1. Interestingly, Chen et al.
found that the catalytic domain of human Chk1 (which re-
sides in the N-terminal half of the protein and thus lacks Thr-
377) is about 20-fold more active than full-length human
Chk1. It will be interesting to observe the disposition of
Thr-377 in the structure of the full-length protein. It is intri-
guing that the critical residues in the SQ/TQ domain that are
required for both the activation and checkpoint function of
Xchk1 (e.g. Thr-314, Ser-344, Ser-356, and Ser-365) are quite
close to Thr-377 in the linear polypeptide sequence of Xchk1
(see Fig. 1A). Thus, it seems plausible that phosphorylation of
Xchk1 in its SQ/TQ domain may relieve an inhibitory con-
straint on kinase activity that could be imposed by the nearby
TRF motif.
The TRF motif is highly conserved in Chk1 proteins from
¢ssion yeast, Drosophila, humans, Xenopus, and other species
(Fig. 1A). Since relatively minimal disruptions in this motif
lead to a large change in kinase activity, it may be possible to
design chemical agents that could enhance the activity of
Chk1 by a similar mechanism. Conversely, agents which pre-
serve or potentiate the e¡ect of the TRF motif may suppress
the function of Chk1. Such approaches might be employed for
the modulation of Chk1 in living cells.
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